The urine test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus and a panel of biomarkers validated by Birmingham University researchers to diagnose bladder cancer.
Read More
Seegene announced that it has signed a partnership with Bio-Rad for the development of infectious disease molecular diagnostic products.
Read More
A team at the UCLA school of medicine and school of engineering developed a high-throughput platform to test thousands of COVID-19 samples.
Read More
Thermo Fisher Scientific has launched a CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0.
Read More
A new corona test developed can analyze a large number of swabs simultaneously using sequencing technology 100 times better than a qPCR test.
Read More